about
Who We Are
TrialsWest was established in 2012. Initially with a focus on respiratory trials, expanding across broad range of therapeutic areas.
We have been involved in numerous phase II to IV clinical trials sponsored by the leading global pharmaceutical companies including GlaxoSmithKline (GSK), AstraZeneca, Novartis, Merck, Sanofi Aventis, Boehringer Ingelheim, Bayer, Pearl Therapeutics and Biogen. It is possible that the time from feasibility to first participant enrolled can be less than 6 weeks. As well, we are consistently one of the highest recruiting sites in Australia, if not globally.
We are located at 226 Main Street in Osborne Park and 6 Barrington Street in Spearwood (Perth, Western Australia).
Our Team
Dr Helen Pavitt
Head of Clinical Trials
BSc Hons, PhD
Since 2004 Helen has been involved in the conduct of over 50 clinical trials (phase Ib, II, III, IV and pre-clinical) in the following therapeutic areas: respiratory, gastroenterology, hepatology, haematology, ENT, nephrology and vaccines. Helen was previously the Clinical Manager at Resonance Health and the Manager of the Clinical Trials Unit at the Lung Institute of Western Australia.
Michelle Davies
Clinical Trials Manager
BSc (Nursing)
Michelle is a registered nurse and has been managing clinical trials for over 15 years. She is experienced in conducting Phase Ib to Phase IV clinical trials in the following indications: respiratory, ENT, vaccines and nephrology. Michelle was previously the Manager of the Clinical Trials Unit at the Lung Institute of Western Australia.
Prof. Peter Bremner
Medical Director
MBChB, FRACP, MD
Professor Bremner is a respiratory physician and has been involved in more than 70 clinical trials over the past 25 years.
This experience has included involvement in phase 1b, II, III and IV clinical trials as both the Principal Investigator and Co-Investigator.